8-KRegulation FDExhibits & Filings

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Feb 18, 2015)

Filed February 18, 2015For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on February 18, 2015, primarily to announce a reaffirmation of its full-year 2015 financial guidance. The company expects net income to be greater than $9.30 per share, which includes an estimated $0.40 per share for the amortization of other intangible assets. Excluding this amortization, the adjusted net income guidance is greater than $9.70 per share. This guidance also explicitly states that it does not anticipate any investment gains or losses for the year 2015.

Key Highlights

  • 1Anthem, Inc. reaffirmed its full-year 2015 net income guidance.
  • 2Projected net income for FY2015 is greater than $9.30 per share.
  • 3Amortization of other intangible assets is expected to impact net income by over $0.40 per share in 2015.
  • 4Adjusted net income guidance for FY2015 is greater than $9.70 per share.
  • 5The company's guidance for 2015 excludes any anticipated investment gains or losses.
  • 6The report includes a press release dated February 18, 2015, as an exhibit.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and reaffirm Anthem, Inc.'s (now Elevance Health, Inc.) financial guidance for the full fiscal year 2015, as detailed in a press release.

Anthem projected its net income for the full year 2015 to be greater than $9.30 per share. This figure includes an estimated impact of over $0.40 per share related to the amortization of other intangible assets.

Excluding the impact of amortization of other intangible assets, Anthem's adjusted net income guidance for 2015 is greater than $9.70 per share.

No, the company explicitly stated that its 2015 guidance includes no investment gains or losses.